Roughly a year and a half after…
Roughly a year and a half after the approval of [...]
Roughly a year and a half after the approval of [...]
Legend Biotech’s interim CEO, Alan Bash, discusses competition from T-cell [...]
Shortly after initiating a separate recall tied to mislabeled pain [...]
Snapchat is courting pharma marketers with a new ad format [...]
Despite their divergent second-quarter performance against consensus estimates, BridgeBio and [...]
President Donald Trump signed an executive order Monday that calls [...]
Nearly three decades after its failed bid for FDA approval, [...]
The FDA has denied ITM Isotopes Technologies’ lead pipeline candidate [...]
Quanterix has hired medtech veteran Jim Gute as chief commercial [...]
Injected weight loss drugs remain favored over newer oral treatments [...]